We serve Chemical Name:2-Bromo-3,4-difluoro-1-nitrobenzene CAS:1003708-24-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-3,4-difluoro-1-nitrobenzene
CAS.NO:1003708-24-4
Synonyms:1-Bromo-2,3-difluoro-4-nitrobenzene;Benzene, 2-bromo-3,4-difluoro-1-nitro-;Benzene, 1-bromo-2,3-difluoro-4-nitro-;2-Bromo-3,4-difluoro-1-nitrobenzene;Benzene, 3-bromo-1,2-difluoro-4-nitro-
Molecular Formula:C6H2BrF2NO2
Molecular Weight:237.986
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:265.5±35.0 °C at 760 mmHg
Density:1.9±0.1 g/cm3
Index of Refraction:1.556
PSA:45.82000
Exact Mass:236.923691
LogP:2.06
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Bromo-2,3-difluoro-4-nitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene, 3-bromo-1,2-difluoro-4-nitro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 1-bromo-2,3-difluoro-4-nitro- Use and application,Benzene, 3-bromo-1,2-difluoro-4-nitro- technical grade,usp/ep/jp grade.
Related News: Along with Natural Biogenix were Symbiotec Pharmalab, Macleods Pharmaceutical, Optimus Drugs, Sudarshan Pharma, Saraca Laboratories, Emmennar Pharma, Hindys Lab, Aarti Speciality, Meghmani LLP and and Sadhana Nitro Chem. 3-benzyl-5-(3-hydroxy-propyl)-[1,3,5]thiadiazinane-2-thione manufacturers This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. (9H-fluoren-9-yl)methyl S-(4-methylbenzyl)-L-cysteinate hydrochloride suppliers Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 1-(3-fluoro-4-methanesulfonylphenyl)-5-(3-methylphenyl)-3-trifluoromethyl-1H-1,2,4-triazole vendor & factory.
